The right ventricle in pulmonary hypertension
暂无分享,去创建一个
K. Chin | L. Rubin | Lewis J Rubin | Kelly M Chin | Nick H S Kim | N. Kim
[1] C. Oakley,et al. Factors that influence the outcome of primary pulmonary hypertension. , 1986, British heart journal.
[2] G. Montalescot,et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. , 1998, The American journal of cardiology.
[3] B. Groves,et al. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[4] S. Mohr-Kahaly,et al. Quantitative assessment of right ventricular volumes in severe chronic thromboembolic pulmonary hypertension using transthoracic three-dimensional echocardiography: changes due to pulmonary thromboendarterectomy. , 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[5] R. Barst,et al. Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.
[6] R. Saouaf,et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[7] T. Sundt,et al. Lung transplantation for pulmonary vascular disease. , 2002, The Annals of thoracic surgery.
[8] L. Rubin. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.
[9] E. Trulock,et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] G. Mielke,et al. Cardiac Output and Central Distribution of Blood Flow in the Human Fetus , 2001, Circulation.
[11] J. Seward,et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.
[12] L. Girling,et al. Treatment of shock in a canine model of pulmonary embolism. , 1984, The American review of respiratory disease.
[13] J. Foster,et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure , 2002, European Respiratory Journal.
[14] A. Waggoner,et al. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. , 2002, The American journal of cardiology.
[15] J. Bronzwaer,et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. , 2004, Chest.
[16] G. Castro. [Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study]. , 2001, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[17] H. Knoblauch,et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. , 1997, Hypertension.
[18] E. Trulock,et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. , 1998, Chest.
[19] P. Lange,et al. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects , 1999, Heart.
[20] M. B. Perryman,et al. Importance of angiotensin-converting enzyme in pulmonary hypertension. , 1995, Cardiology.
[21] A. Torbicki,et al. Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension , 2003, Circulation.
[22] S. Mohr-Kahaly,et al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. , 2000, Chest.
[23] R. Matthay,et al. The right ventricle in pulmonary disease. , 1992, Cardiology clinics.
[24] E. Robin,et al. PRIMARY PULMONARY HYPERTENSION , 2022 .
[25] M. Sklansky,et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. , 1999, The American journal of cardiology.
[26] N. Morrell,et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. , 2002, American journal of respiratory and critical care medicine.
[27] J B Seward,et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.
[28] F. Lallemand,et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. , 1997, Circulation.
[29] R. Quaife,et al. The pressure-overloaded right ventricle in pulmonary hypertension. , 1998, Chest.
[30] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[31] G. Koch,et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.
[32] A. Ambergen,et al. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[33] F. Wackers,et al. Assessment of right ventricular morphology and function. , 2003, Seminars in respiratory and critical care medicine.
[34] B. Brundage,et al. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. , 1995, Circulation.
[35] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[36] R. Virmani,et al. Anatomy and pathology of the right ventricle (including acquired tricuspid and pulmonic valve disease). , 1992, Cardiology clinics.
[37] K. Hirata,et al. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[38] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[39] A. Wells,et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. , 1997, British journal of rheumatology.
[40] H. Ito,et al. Endothelins and cardiac hypertrophy. , 1997, Life sciences.
[41] V. Aiello,et al. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. , 2002, The Journal of thoracic and cardiovascular surgery.
[42] J. Sandoval,et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.
[43] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[44] R. Favaloro,et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[45] W. Kuebler,et al. The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo , 2003, Intensive Care Medicine.
[46] G. Koch,et al. Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .
[47] Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.
[48] M. Hoeper,et al. Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension , 2003, Heart.